Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100,000
Closed -$9.88M 43
2025
Q4
$9.88M Hold
100,000
0.61% 26
2025
Q3
$8.48M Buy
+100,000
New +$7.9M 0.71% 21
2023
Q3
Sell
-77,500
Closed -$4.82M 41
2023
Q2
$4.82M Hold
77,500
0.42% 29
2023
Q1
$5.6M Hold
77,500
0.46% 33
2022
Q4
$6.22M Buy
+77,500
New +$5.93M 0.48% 33

Other funds holding INCY

Casdin Capital's INCY Position: Q1 2026 in Review

Casdin Capital sold out of Incyte (INCY) in Q1 2026, closing a stake of 100,000 shares — an estimated $9.88M sold.

Casdin Capital first reported a position in INCY in Q4 2022 and held it in 5 quarters. The position peaked at $9.88M in Q4 2025. 811 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

  • Casdin Capital reported no remaining Incyte position as of Q1 2026 after selling out during the quarter.
  • Casdin Capital sold 100,000 Incyte shares in Q1 2026, an estimated $9.88M.
  • Casdin Capital first reported a position in Incyte in Q4 2022 and held it in 5 quarters.
  • Casdin Capital's Incyte position peaked at $9.88M in Q4 2025.
  • 811 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on Casdin Capital's 13F filing for Q1 2026, filed 15 May 2026.